Surveillance of infectious complications associated with central venous access devices in children with haemophilia

Haemophilia. 2003 Sep;9(5):588-92. doi: 10.1046/j.1365-2516.2003.00793.x.

Abstract

Purpose: To analyse the risk factors for infection associated with central venous access device (CVAD) use in children with haemophilia.

Methods: Risk factors for CVAD infection among patients with congenital haemophilia who had had a CVAD implanted at a single institution were evaluated utilizing the following variables: age at CVAD placement, age at end of study, number of days with a CVAD, percentage of lifetime with a CVAD, and history of inhibitor.

Results: Fifty-nine patients had a total of 97,936 (median 1768 days per patient) CVAD days in the study period. The median age at CVAD placement was 2.7 years (range 0-14.0). Twenty-six (44%) patients reported CVAD infections during the study period from January 1993 to October 2000. Twenty-four patients had their CVAD replaced, 17 (71%) of whom reported having infections and seven (29%) of whom had a history of inhibitor. The strongest predictor for having any infections was inhibitor status (P=0.16), although none of the risk factors had statistically significant effects. Among the 26 patients reporting infections, 42% had more than one CVAD-related infection. Seven patients had multiple infections involving the same organism. The mean rate of infection was 0.45 per 1000 catheter days, with a 95% confidence interval of 0.33-0.60. Those with a history of inhibitor had an infection rate of 0.66 compared with 0.38 per 1000 catheter days (P=0.09) for those without a history of inhibitor. Patients who were older (greater than the median age of 2.7) at CVAD placement had a lower rate of infection (0.29 vs. 0.65, P<0.01) compared with those < or =2.7 years. Adjustment for inhibitor status had little impact on these results. For the group as a whole, the median time to first infection was 1977 days from CVAD placement. Patients who were older at CVAD placement or study exit had lower relative hazards of infection (P=0.05 and P=0.09 respectively), while those who had inhibitors had a higher but not statistically significant relative hazard of 1.88 (P=0.13).

Conclusions: These data reveal that while considerable numbers of patients develop CVAD-related infection, the interval between catheter placement and infection can be quite long. In addition, the earlier in life a CVAD is placed, the higher the risk of infectious complications, as evidenced by the tendency towards a higher infection rate. Measures to prevent CVAD-related infection might be focused on very young patients who appear to be at higher risk.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Catheterization, Central Venous / adverse effects*
  • Catheters, Indwelling / adverse effects
  • Child
  • Child, Preschool
  • Equipment Contamination*
  • Factor VIII / antagonists & inhibitors
  • Factor VIII / immunology
  • Hemophilia A / complications*
  • Hemophilia A / immunology
  • Humans
  • Infant
  • Infant, Newborn
  • Infections / etiology*
  • Isoantibodies / blood
  • Longitudinal Studies
  • Male
  • Risk Factors
  • Time Factors

Substances

  • Isoantibodies
  • Factor VIII